Acadia Pharmaceuticals Inc.

ACADIA Pharmaceuticals Misses on EPS, Stock Down 0.8%

ACADIA Pharmaceuticals reported a loss per share of $0.50, which was slightly better than expected. However, the stock fell by 0.8% following the earnings report, indicating that investors may have been looking for more positive news or guidance. The lack of revenue figures and management commentary could have contributed to the stock's decline.